SCOPE 2023: Concerns With Clinical Technology

Overcoming hurdles with licensing complexities, post-production changes, and IRB submissions can help in reducing timelines and increasing collaboration.

Strategies for ensuring that innovation with PROs remains parallel with advancements in disease detection and progression.

Addressing data integrity and compliance concerns.

In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.

Conference breakout session explores strategies for trial sites to strengthen patient relationships.

Conference breakout session examines the role of strategic partnerships in driving progress for sexual and gender minority inclusion in clinical research.